Ambulances delays lead Wilmslow GPs to drive patient to A&E

Two Wilmslow doctors say the NHS is “broken” after they had to drive a patient to A&E themselves.

Share Button

Child obesity in pandemic could have lifelong effects, study says

Researchers say children who gained weight in the pandemic could develop diseases later in life.

Share Button

Tories Heading For An Electoral ‘Iceberg’ Under Rishi Sunak, Says Simon Clarke

The Tories are heading towards an electoral “iceberg” unless Rishi Sunak is dumped as leader, Simon Clarke has warned.

The former cabinet minister – who last night called for the prime minister to be ousted by his MPs – said the Conservatives are heading for “a shattering defeat” unless they change course.

His comments, in an interview with the BBC, is a further challenge to Sunak’s authority as he struggles to turn around his party’s fortunes.

In an article in today’s Daily Telegraph, Clarke said the Tories were “meekly sleepwalking towards an avoidable annihilation” with Sunak at the helm.

That led to a furious backlash from senior Conservatives, including former ministers David Davis, Liam Fox and Priti Patel.

But Clarke told the BBC he was undeterred and re-iterated his desire to see Sunak booted out of No.10 before the general election.

He said: “I’ve incurred some pretty hostile comments from a number of people and look, you know, in every since I’m a big guy, I can take that and I totally respect the strong views that something like this evokes, right.

“No one likes the guy who’s shouting ‘iceberg’. But I suspect that people will be even less happy if we hit the iceberg. And we are on course to do that.”

The former Treasury secretary added: “I want a Conservative government that delivers for communities like mine and for our country. And I really worry that we are on course for a shattering defeat.”

Clarke said it was “a moment of decision for the Conservative Party” and pointed out that the opinion polls had got even worse for the Tories under Sunak.

“There is really compelling evidence that we are on course for what I would say is an avoidable catastrophe,” he said.

“I think there is a very real risk that because we’re not connecting with the British public because, frankly, the prime minister is not listening to the things that the public really wants us to address, in particular on migration, that we end up with a very serious election defeat and then a decade of decline or more under Keir Starmer.”

Share Button

Paloma Diamond Fans Can’t Wait For Her To Win An Oscar. But The Thing Is, She Doesn’t Exist

If you’re on TikTok at all, you might recognise the name Paloma Diamond. The character is the creation of New Zealand TikToker Julian Sewell, who has been posing as Diamond ever since October last year.

In a TikTok that currently has over 19 million views, Sewell aped the Academy Awards with a flawless parody called “Every Best Actress Award Intro”. In it, an announcer introduces five fictional actresses and their (impeccably named) non-existent films, including Paloma Diamond.

The hilarious TikTok went viral, spawning countless write-ups around the world, and has caused Sewell’s following to surge across various platforms.

In an interviewer with Sunday Magazine via The Post, Sewell commented that he didn’t mean to create a new cinematic universe, but is happy with the response he’s gotten so far.

“I [get] an influx of really kind and supportive messages from people I’ve never met before, saying ‘oh my god you make my day,’ or ‘I was having an awful day until I saw your video and it made me laugh’ – and that’s all that matters.”

Since his first video, Sewell’s best actress characters have developed their own currency online, with users across Instagram, X and TikTok all desperate to see more from the likes of Lorelai Lynch and Taylor Witherfork.

But none are more sought after than Diamond, who Sewell has really run with, posting parodies of the Meryl Streep-esque performer taking part in Vogue’s 73 Questions and The Hollywood Reporter’s Actress Roundtable series.

One of the ongoing gags in the Paloma Diamond universe is the fact that the “actress” has been nominated for an Oscar 18 times, but has never won one. Well, as of 2024, Diamond has another nomination, and fans are keen to see her finally take home the coveted award.

Here’s how some X users have reacted online to Diamond’s nomination…

Here’s hoping Diamond gets her much-deserved flowers at this year’s ceremony on 10 March.

Share Button

Bullying ‘normal occurrence’ at Newcastle NHS trust, say CQC

Newcastle Hospitals NHS Foundation Trust’s CQC rating is downgraded to “requires improvement”.

Share Button

Footballer Michael Owen on son’s sight loss: ‘I’d swap eyes with him if I could’

The father and son on getting to grips with a degenerative eye condition.

Share Button

Millions lose access to free NHS earwax removal

Patients unable to afford private treatment are turning to “dangerous self-removal methods”, the RNID says.

Share Button

Injectable water filtration system could improve access to clean drinking water around the world

More than 2 billion people, approximately a quarter of the world’s population, lack access to clean drinking water. A new, portable and affordable water filtration solution created by researchers at The University of Texas at Austin aims to change that.

The new system collects dirty water with a syringe and injects it into a hydrogel filter that weeds out nearly all tiny particles. This device, the researchers say, offers significant advantages in cost, simplicity, effectiveness and sustainability compared existing commercial options, giving users the ability to easily decontaminate water from nearby streams and rivers and make it drinkable.

“The pressing concern of particle-polluted water, particularly in remote and underdeveloped regions where people frequently rely on contaminated water sources for consumption, demands immediate attention and recognition,” said Guihua Yu, a professor of materials science at the Cockrell School of Engineer’s Walker Department of Mechanical Engineering and Texas Materials Institute. “Our system, with its high efficiency in removing diverse types of particles, offers an attractive yet practical solution in improving freshwater availability.”

The research was published recently in Nature Sustainability.

Today’s options for portable water filtration of tiny particles mostly consist of filter paper and microporous membranes. According to the research, these devices filter out roughly 40% and 80% of particles larger than 10 nanometers, respectively. This new system catches close to 100% of these particles.

And it is made of low-cost, sustainable, readily available materials. The main innovation is an intertwined web of nanocellulose fibers that catches particles while the newly cleaned water passes through.

All the user has to do is take the syringe to the nearest water source, pull out the water and inject it through the filter. The system takes care of the rest, spitting out clean, drinkable water.

The filter system has been tested with several types of water sources, including muddy water, river water and water contaminated with microplastics. The hydrogel films are biodegradable and can be used up to 30 times before they need to be replaced.

The research team has tested the technology using syringes as large as 1.5 liters, about 40% of an individual’s daily drinking water needs. And they plan to continue developing the technology to use it at larger scales to tackle global drinking water needs.

The researchers were motivated by one of the United Nations’ Sustainable Development Goals to improve drinking water standards and sanitation worldwide. Meeting this goal, according to the U.N., will require a 6X increase in drinking water availability by 2030.

“The reality is, a large percentage of the world’s population lacks access to safe drinking water, even in places where fresh water sources are available,” said Chuxin Lei, lead author and a graduate student working in Yu’s lab, said. “There is an urgent need for simple, universal, and efficient materials and devices for purifying particle-contaminated water, which should be able to help people around the world obtain clean water.”

Team members on the project also include collaborators from Northeast Forestry University, Shanghai Tech University and Tsinghua University in China.

Share Button

Popular diabetes drug may also reduce the risk of severe liver disease

Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet in Sweden published in the journal Gut.

GLP1 agonists like Ozempic reduce blood sugar levels and are mainly used to treat type 2 diabetes. However, as the drug also reduces appetite, it is now increasingly used to treat obesity and has become a popular weight-loss drug.

Reduced risk of liver damage

Results from early clinical trials also suggest that GLP1 agonists may reduce the risk of liver damage. Therefore, researchers at Karolinska Institutet included all people in Sweden with chronic liver disease and type 2 diabetes in a register-based study. They then compared the risk of severe liver damage in those who were treated with GLP1 agonists and those who were not. The results show that those who took the drug for a long period of time had a lower risk of later developing more severe forms of liver disease such as cirrhosis and liver cancer.

According to the researchers, this suggests that GLP1 agonists could be an effective treatment to avoid severe liver disease in people with concurrent type 2 diabetes.

“Fatty liver disease is estimated to affect up to one in five people in Sweden, many of whom have type 2 diabetes, and about one in twenty develop severe liver disease,” says first author Axel Wester, assistant professor at the Department of Medicine, Huddinge, Karolinska Institutet. “Our findings are interesting because there are currently no approved drugs to reduce this risk.”

Many of the people in the study stopped taking GLP1 agonists, resulting in a lack of protective effect. However, those who continued taking their medication over a ten-year period were half as likely to develop severe liver disease.

Need to be confirmed

“The results need to be confirmed in clinical trials, but it will take many years for these studies to be completed,” says Axel Wester. “Therefore, we use existing registry data to try to say something about the effect of the drugs before that.”

A limitation of the method is that it is not possible to control for factors for which there is no data, such as blood tests to describe the severity of liver disease in more detail. However, the researchers have recently built a new database called HERALD where they have access to blood samples from patients in Region Stockholm.

“As a next step, we will investigate the effect of GLP1 agonists in this database,” says the study’s last author Hannes Hagström, consultant in hepatology at the Karolinska University Hospital and adjunct professor at the Department of Medicine, Huddinge, Karolinska Institutet. “If we get similar results, it would further strengthen the hypothesis that GLP1 agonists can be used to reduce the risk of severe liver disease.”

The research was mainly funded by Region Stockholm (CIMED), the Swedish Research Council and the Swedish Cancer Society. Hannes Hagström’s research group has received funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD, Novo Nordisk and Pfizer, although no industry-supported funding was obtained for this specific study.

Share Button

Gene expression atlas captures where ovulation can go awry

An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice.

The resulting atlas reveals a slew of previously unknown cellular and molecular interactions that drive ovulation, which is crucial for female fertility. The findings could prove pivotal for developing therapeutic treatments for infertility.

The research, published Jan. 22 in Proceedings of the National Academy of Sciences, was led by Iwijn De Vlaminck, associate professor of biomedical engineering in Cornell Engineering, and Yi Ren, assistant professor of animal science in the College of Agriculture and Life Sciences. The paper’s lead author is Madhav Mantri, Ph.D. ’23, now a postdoctoral researcher at Stanford University.

De Vlaminck previously used the imaging method, high-resolution spatiotemporal transcriptomics, to survey the entire spectrum of RNA in mouse tissues, which showed the role of elusive RNA in skeletal muscle regeneration and viral myocarditis. Transcriptomics essentially converts RNA into DNA copies, which are tagged with barcodes that capture their spatial location — data that can then be sequenced into an image.

In 2022, De Vlaminck gave a presentation on the myocarditis findings at the 2nd Intercampus Immunology Symposium, which Ren attended. She was intrigued by De Vlaminck’s approach and wondered if it could be applied to one of her chief interests: unraveling the cellular and molecular mechanisms that regulate ovulation.

Ovulation requires accurate coordination between female germ cells, called oocytes, and their release via the rupture of ovarian follicles, which provide the environment for oocytes to grow and mature. In mice, this rupture occurs every four to five days; in women, it’s approximately every four weeks. Oocytes expire quickly once they depart the ovary, so the timing of their release is critical.

“Ovarian follicles are like launching pads, and the ovary is like the ground control. Together they prepare the eggs for fertilization at the right time and right location,” Ren said. “All the different cell types in the ovary must work together through an amazingly complex and dynamic ‘social network’ that involves intricated communication between all cells. That’s the power of Iwijn’s technology. It combines high resolution in both time and space. So those two really capture the essence of ovulation.”

In the years since De Vlaminck’s myocarditis study, the spatial resolution of transcriptomics has significantly improved, from 100 micrometers to 10 microns per pixel — a tenfold enhancement that has resulted in near single-cell resolution. The flip side to obtaining so much data, however, is that parsing it all is daunting.

“We had about 10 images and we spent a good 10 months making sense of them,” De Vlaminck said.

For each image, the researchers sequenced hundreds of millions of DNA molecules, then translated them into a matrix of gene expression. Every pixel contained the expression level of all 22,000 protein-coding genes in the mouse genome. Multiply that by approximately 100,000 pixels. And that was only the beginning.

“You have to turn that data into biological findings, look at temporal patterns, fish out specialized cell states and so on,” De Vlaminck said. “It’s not just like a normal microscopy image where you have the image, and that’s it, you see what you see.”

Among the findings, the atlas reveals that roughly one hour before an egg is released, the follicles undergo an additional layer of selection to determine which ones will ovulate. This acute process had never been identified before, and when it goes awry, it may lead to reduced ovulation rates and could hinder fertility. The researchers were also able to detect early differentiation markers that decide the different paths cells may take in the ovary. In effect, the atlas captures dynamic cellular and molecular control programs in both the very early and very late stages of ovulation.

“This type of atlas provides so much more detail about where and when all the molecular changes happen in the ovary, details that were difficult to capture using other methodologies,” De Vlaminck said. “So that may inspire new interventions that target specific molecules we identify, for example, specific genes that are important for fertility management.”

Now De Vlaminck and Ren, who are both faculty with the Cornell Reproductive Sciences Center, plan to extend their collaboration into exploring fertility and ovulation problems associated with obesity and reproductive aging.

In the U.S. alone, more than 10% of infertility cases are caused by ovulation failure, the researchers noted, a problem that is exacerbated by increasing obesity, and maternal age.

“There is a growing interest at Cornell in these types of problems, where we can use cutting-edge engineering principles for reproductive medicine — an area where those cutting-edge tools are not used as much, or as early, as in some other fields, like cancer biology, for instance,” De Vlaminck said.

Co-authors include doctoral student Hanxue Hannah Zhang and Emmanuel Spanos ’24.

The research was supported by the Cornell Center of Vertebrate Genomics and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Share Button